title: Fibronectin type III5 repeat contains a novel cell adhesion sequence, KLDAPT, which binds activated alpha4beta1 and alpha4beta7 integrins.
abstract: The region of fibronectin encompassing type III repeats 4-6 contains a low affinity heparin binding domain, but its physiological significance is not clear. We have studied whether this domain is able to interact with cells as already shown for other heparin binding domains of fibronectin. A computer search based on homologies with known active sites in fibronectin revealed the sequence KLDAPT located in FN-III5. A synthetic peptide containing this sequence induced lymphoid cell adhesion upon treatment with the activating anti-beta1 monoclonal antibody (mAb) TS2/16 or with Mn2+, indicating that KLDAPT was binding to an integrin. A recombinant fragment containing repeat III5 (FN-III5) also mediated adhesion of TS2/16/Mn2+-treated cells while the FN-III6 fragment did not. Soluble KLDAPT peptide inhibited cell adhesion to FN-III5 as well as to a 38-kDa fibronectin fragment and VCAM-1, two previously known ligands for alpha4beta1 integrin. KLDAPT also competed with the binding of soluble alkaline phosphatase-coupled VCAM-Ig to Mn2+-treated alpha4beta1. Furthermore, mAbs anti-alpha4 and anti-alpha4beta7, but not mAbs to other integrins, inhibited cell adhesion to FN-III5 and KLDAPT. These results therefore establish a cell adhesive function for the FN-III5 repeat and show that KLDAPT is a novel fibronectin ligand for activated alpha4 integrins.
authors.affiliation: Departamento de Inmunología, Centro de Investigaciones Biológicas, CSIC, 28006 Madrid, Spain.
authors.forename: J V
authors.initials: JV
authors.lastname: Moyano
authors.forename: B
authors.initials: B
authors.lastname: Carnemolla
authors.forename: C
authors.initials: C
authors.lastname: Domínguez-Jiménez
authors.forename: M
authors.initials: M
authors.lastname: García-Gila
authors.forename: J P
authors.initials: JP
authors.lastname: Albar
authors.forename: P
authors.initials: P
authors.lastname: Sánchez-Aparicio
authors.forename: A
authors.initials: A
authors.lastname: Leprini
authors.forename: G
authors.initials: G
authors.lastname: Querzé
authors.forename: L
authors.initials: L
authors.lastname: Zardi
authors.forename: A
authors.initials: A
authors.lastname: Garcia-Pardo
mesh_terms: D000595:Amino Acid Sequence; D000911:Antibodies, Monoclonal; D001402:B-Lymphocytes; D001665:Binding Sites; D002448:Cell Adhesion / Q000187:drug effects; D002460:Cell Line; D005353:Fibronectins / Q000737:chemistry* / Q000378:metabolism*; D006801:Humans; D039041:Integrin alpha4beta1; D016023:Integrins / Q000378:metabolism*; D019169:Jurkat Cells; D008024:Ligands; D008345:Manganese / Q000494:pharmacology; D008969:Molecular Sequence Data; D010446:Peptide Fragments / Q000737:chemistry / Q000378:metabolism / Q000494:pharmacology; D010455:Peptides / Q000737:chemistry / Q000378:metabolism; D016201:Receptors, Lymphocyte Homing / Q000378:metabolism*; D011994:Recombinant Proteins / Q000737:chemistry / Q000378:metabolism; D016415:Sequence Alignment; D013601:T-Lymphocytes; D014407:Tumor Cells, Cultured; D019010:Vascular Cell Adhesion Molecule-1 / Q000378:metabolism
chemical_list: D000911:Antibodies, Monoclonal; D005353:Fibronectins; D039041:Integrin alpha4beta1; D016023:Integrins; D008024:Ligands; D010446:Peptide Fragments; D010455:Peptides; D016201:Receptors, Lymphocyte Homing; D011994:Recombinant Proteins; D019010:Vascular Cell Adhesion Molecule-1; C071777:integrin alpha4beta7; D008345:Manganese